Hillstream BioPharma, Inc. (HILS) NASDAQ
0.24
+0.0127(+5.66%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.24
+0.0127(+5.66%)
Currency In USD
| Market Cap | 5.8M |
| Enterprise Value | -11.23M |
| P/E Ratio | -0.61 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.1 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.69 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.14 |
| Return On Equity | -0.37 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -20.11M |
| Net Income | -35.92M |
| Diluted EPS | -1.12 |
| Total Cash | 41.53M |
| Total Cash/Share | 0.2 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 37.75 |
| Book Value Per Share | 2.26 |
| 52-Week Change | -63.65 |
| 52-Week High | 2.65 |
| 52-Week Low | 0.17 |
| Moving Average 50 Days | 0.25 |
| Moving Average 200 Days | 0.58 |
| Average Volume | 684,778 |
| Shares Outstanding | 17.6M |
| % Held by Institutions | 1.61 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |